Physician Differences in Managing Postmenopausal Osteoporosis: Results from the POSSIBLE US™ Treatment Registry Study

ISSN： 1170-229X

Source： Drugs & Aging, Vol.28, Iss.9, 2011-09, pp. : 713-727

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lasofoxifene, from the preclinical drug discovery to the treatment of postmenopausal osteoporosis

By Gennari Luigi Merlotti Daniela Stolakis Konstantinos Nuti Ranuccio

Expert Opinion on Drug Discovery, Vol. 6, Iss. 2, 2011-02 ,pp. : 205-217

Informa Healthcare

Access to resources Recommend Favorite

Clodronic Acid in the Treatment of Postmenopausal Osteoporosis

By Tanakol Refik

Clinical Drug Investigation, Vol. 27, Iss. 6, 2007-01 ,pp. : 419-433

Adis International

Access to resources Recommend Favorite

Explaining Differences in Hepatitis C Between U.S. Veterans and Nonveterans in Treatment for Substance Abuse: Results From a Regression Decomposition

By Heslin Kevin C.

Substance Use & Misuse, Vol. 48, Iss. 10, 2013-08 ,pp. : 854-862

Informa Healthcare

Access to resources Recommend Favorite

Dismal outcome of t‐cell lymphoma patients failing first‐line treatment: results of a population‐based study from the Modena Cancer Registry

Hematological Oncology (Electronic), Vol. 33, Iss. 3, 2015-09 ,pp. : 147-151

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dismal outcome of t‐cell lymphoma patients failing first‐line treatment: results of a population‐based study from the Modena Cancer Registry

Hematological Oncology (Electronic), Vol. 278-0232, Iss. 3, 2015-09 ,pp. : 147-151

John Wiley & Sons Inc

Access to resources Recommend Favorite